Objective: To assess whether the coronavirus disease 2019 (COVID-19) mRNA vaccine affects sperm morphokinetics using a computer-assisted semen analyzer and other semen parameters using a sperm chromatin structure assay.
Methods: Healthy male volunteers in two Japanese clinics between May 2021 and December 2021 were prospectively analyzed. Participants donated sperm twice, two days apart, in the following phases: before vaccination, 2 weeks after the first vaccine dose, and 2, 4, and 12 weeks after the second dose. Basic sperm parameters, sperm motility characteristics, and the percentage of DNA-damaged sperm were compared among the different phases.
Results: Ninety-six semen samples from ten volunteers, who were vaccinated with the BNT162b2 mRNA vaccine, were evaluated. There were no significant differences between any phases in basic semen findings and parameters of the sperm chromatin structure assays. Regarding sperm motion characteristics, the average linear velocity, beat-cross frequency, and sperm motility index significantly decreased after the second vaccine dose (P=0.018, P=0.003, and P=0.027, respectively), with no significant differences between any two phases by post-hoc pairwise comparisons.
Conclusions: After COVID-19 mRNA vaccination, while sperm motion characteristics might fluctuate, no apparent deterioration of basic sperm parameters or sperm DNA integrity was observed. Given the adverse effects of COVID-19 on sperm, our findings suggest that there might be no reason to refrain from vaccination for healthy individuals.
Conflict of interest statement
The authors declare no conflicts of interest.
Funding
This study received no extramural funding.
Authors’ contributions
Yasuhiro Ohara was the principal investigator in this study, designed the study, collected the data, performed statistical analyses, analyzed the data, and drafted the manuscript. Dr Shimpei Mizuta designed the study, collected the data, performed statistical analyses, analyzed the data, and reviewed the manuscript. Dr Hidehiko Matsubayashi, and Dr Tomomoto Ishikawa, supported the collection of data, helped in review of literature, reviewed the manuscript. Dr Tsuyoshi Takiuchi and Dr Tadashi Kimura designed the study and revised the manuscript. All the authors approved the manuscript for publication.
| [1] |
Ministry of Health, Labour and Welfare. Handbook of health and welfare statistics, 2021. [Online] Available from:https://www.mhlw.go.jp/english/database/db-hh/1-2.html [Accessed 3rd March 2023].
|
| [2] |
Ata B, Vermeulen N, Mocanu E, Gianaroli L, Lundin K, Rautakallio-Hokkanen S, et al. SARS-CoV-2, fertility and assisted reproduction. Hum Reprod Update 2022 doi: 10.1093/humupd/dmac037.
|
| [3] |
Li H, Xiao X, Zhang J, Zafar MI, Wu C, Long Y, et al. Impaired spermatogenesis in COVID-19 patients. E Clinical Medicine 2020; 28:100604.
|
| [4] |
Navarra A, Albani E, Castellano S, Arruzzolo L, Levi-Setti PE. Coronavirus disease-19 infection: Implications on male fertility and reproduction. Front Physiol 2020; 11:574761.
|
| [5] |
Patel DP, Punjani N, Guo J, Alukal JP, Li PS, Hotaling JM. The impact of SARS-CoV-2 and COVID-19 on male reproduction and men’s health. Fertil Steril 2021; 115(4):813-823.
|
| [6] |
Gonzalez DC, Nassau DE, Khodamoradi K, Ibrahim E, Blachman-Braun R, Ory J, et al. Sperm parameters before and after COVID-19 mRNA vaccination. JAMA 2021; 326(3):273-274.
|
| [7] |
Safrai M, Herzberg S, Imbar T, Reubinoff B, Dior U, Ben-Meir A. The BNT162b2 mRNA Covid-19 vaccine does not impair sperm parameters. Reprod Biomed Online 2022; 44(4):685-688.
|
| [8] |
Lifshitz D, Haas J, Lebovitz O, Raviv G, Orvieto R, Aizer A. Does mRNA SARS-CoV-2 vaccine detrimentally affect male fertility, as reflected by semen analysis? Reprod Biomed Online 2022; 44(1):145-149.
|
| [9] |
Zhu H, Wang X, Zhang F, Zhu Y, Du MR, Tao ZW, et al. Evaluation of inactivated COVID-19 vaccine on semen parameters in reproductive-age males: A retrospective cohort study. Asian J Androl 2022; 24(5):441-444.
|
| [10] |
Zaçe D, La Gatta E, Petrella L, Di Pietro ML. The impact of COVID-19 vaccines on fertility: A systematic review and meta-analysis. Vaccine 2022; 40(42):6023-6034.
|
| [11] |
Huang J, Xia L, Tian L, Xu D, Fang Z, Lin J, et al. Comparison of semen quality before and after inactivated SARS-CoV-2 vaccination among men in China. JAMA Netw Open 2022; 5(9):e2230631.
|
| [12] |
Marinaro JA, Schlegel PN. Sperm DNA damage and its relevance in fertility. treatment: A review of recent literature and current practice guidelines. Int J Mol Sci 2023; 24(2):1446.
|
| [13] |
Agarwal A, Majzoub A, Baskaran S, Panner Selvam MK, Cho CL, Henkel R, et al. Sperm DNA fragmentation: A new guideline for clinicians. World J Mens Health 2020; 38(4):412-471.
|
| [14] |
Aghazarian A, Huf W, Pflüger H, Klatte T. Standard semen parameters vs. sperm kinematics to predict sperm DNA damage. World J Mens Health 2021; 39(1):116-122.
|
| [15] |
Sivanarayana T, Krishna C, Prakash GJ, Krishna KM, Madan K, Rani BS, et al. CASA derived human sperm abnormalities: Correlation with chromatin packing and DNA fragmentation. J Assist Reprod Genet 2012; 29(12):1327-1334.
|
| [16] |
Kruger T. Computer-assisted sperm analysis systems: Morphometric aspects. Hum Reprod 1995; 10(Suppl 1):46-52.
|
| [17] |
Boe-Hansen GB, Fedder J, Ersboll AK, Christensen P. The sperm chromatin structure assay as a diagnostic tool in the human fertility clinic. Hum Reprod 2006; 21(6):1576-1582.
|
| [18] |
World Health Organization. WHO laboratory manual for the examination and processing of human semen, 6th edition, 2021. [Online] Available from:https://www.who.int/publications/i/item/9789240030787 [Accessed 3rd March 2023].
|
| [19] |
Fujihara Industry. Sperm motility and morphology analysis system "SMAS". [Online] Available from:https://www.fujihira.co.jp/english/chk/SMAS.html [Accessed 3rd March 2023].
|
| [20] |
Akashi T, Watanabe A, Komiya A, Fuse H. Evaluation of the sperm motility analyzer system (SMAS) for the assessment of sperm quality in infertile men. Syst Biol Reprod Med 2010; 56(6):473-477.
|
| [21] |
Barda S, Laskov I, Grisaru D, Lehavi O, Kleiman S, Wenkert A, et al. The impact of COVID-19 vaccine on sperm quality. Int J Gynaecol Obstet 2022; 158(1):116-120.
|
| [22] |
Cohen J. A power primer. Psychol Bull 1992; 112(1):155-159.
|
| [23] |
Diaz P, Dullea A, Patel M, Blachman-Braun R, Reddy R, Khodamoradi K, et al. Long-term evaluation of sperm parameters after coronavirus disease 2019 messenger ribonucleic acid vaccination. F S Rep 2022; 3(3):211213.
|
| [24] |
Reschini M, Pagliardini L, Boeri L, Piazzini F, Bandini V, Fornelli G, et al. COVID-19 Vaccination does not affect reproductive health parameters in men. Front Public Health 2022; 10:839967.
|
| [25] |
Karavani G, Chill HH, Meirman C, Gutman-Ido E, Herzberg S, Tzipora T, et al. Sperm quality is not affected by the BNT162b2 mRNA SARS-CoV-2 vaccine: Results of a 6-14 months follow-up. Assist Reprod Genet 2022; 39(10):2249-2254.
|
| [26] |
Soleimanpour S, Yaghoubi A. COVID-19 vaccine: Where are we now and where should we go? Expert Rev Vaccines. 2021; 20(1):23-44.
|
| [27] |
Gat I, Kedem A, Dviri M, Umanski A, Levi M, Hourvitz A, et al. Covid-19 vaccination BNT162b2 temporarily impairs semen concentration and total motile count among semen donors. Andrology 2022; 10(6):10161022.
|
| [28] |
Abd ZH, Muter SA, Saeed RAM, Ammar O. Effects of Covid-19 vaccination on different semen parameters. Basic Clin Androl 2022; 32(1):13.
|
| [29] |
Abdelhamid MHM, Fellah AA, Elmarghani A, Al Msellati IA. An assessment of men semen alterations in SARS-CoV-2: Is fever the principal concern? Reprod Sci. 2023; 30(1):72-80.
|
| [30] |
Holtmann N, Edimiris P, Andree M, Doehmen C, Baston-Buest D, Adams O, et al. Assessment of SARS-CoV-2 in human semen: A cohort study. Fertil Steril 2020; 114(2):233-238.
|
| [31] |
Lewis SE, John Aitken R, Conner SJ, Iuliis GD, Evenson DP, Henkel R, et al. The impact of sperm DNA damage in assisted conception and beyond: Recent advances in diagnosis and treatment. Reprod Biomed Online 2013; 27(4):325-337.
|
| [32] |
Virro MR, Larson-Cook KL, Evenson DP. Sperm chromatin structure assay (SCSA) parameters are related to fertilization, blastocyst development, and ongoing pregnancy in in vitro fertilization and intracytoplasmic sperm injection cycles. Fertil Steril 2004; 81(5):1289-1295.
|
| [33] |
Zhu C, Chen F, Zhang S, She H, Ju Y, Wen X, et al. Influence of sperm DNA fragmentation on the clinical outcome of in vitro fertilization-embryo transfer (IVF-ET). Front Endocrinol 2022; 13:945242.
|
| [34] |
Zhang F, Li J, Liang Z, Wu J, Li L, Chen C, et al. Sperm DNA fragmentation and male fertility: A retrospective study of 5 114 men attending a reproductive center. J Assist Reprod Genet 2021; 38(5):1133-1141.
|
| [35] |
Zidi-Jrah I, Hajlaoui A, Mougou-Zerelli S, Kammoun M, Meniaoui I, Sallem A, et al. Relationship between sperm aneuploidy, sperm DNA integrity, chromatin packaging, traditional semen parameters, and recurrent pregnancy loss. Fertil Steril 2016; 105(1):58-64.
|
| [36] |
Takeshima T, Usui K, Mori K, Asai T, Yasuda K, Kuroda S, et al. Oxidative stress and male infertility. Reprod Med Biol 2020; 20(1):41-52.
|
| [37] |
Olana S, Mazzilli R, Salerno G, Zamponi V, Tarsitano MG, Simmaco M, et al. 4BNT162b2 mRNA COVID-19 vaccine and semen: What do we know? Andrology 2022; 10(6):1023-1029.
|